Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

China · Delayed Price · Currency is CNY

16.16

-0.48 (-2.88%)

Nov 6, 2026, 3:00 PM CST

Market Cap	13.88B -19.0%
Revenue (ttm)	5.28B -1.3%
Net Income	599.20M -17.1%
EPS	0.67 -18.1%
Shares Out	859.19M
PE Ratio	24.09
Forward PE	16.19
Dividend	0.20 (1.24%)
Ex-Dividend Date	Sep 11, 2026

Volume	17,036,277
Open	16.19
Previous Close	16.64
Day's Range	15.98 - 16.65
52-Week Range	12.05 - 22.25
Beta	0.20
Analysts	Buy
Price Target	19.20 (+18.81%)
Earnings Date	Oct 22, 2026

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1973

Employees 4,791

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603456

Full Company Profile

Financial Performance

In 2025, SHA:603456's revenue was 5.51 billion, an increase of 6.74% compared to the previous year's 5.16 billion. Earnings were 730.07 million, an increase of 20.46%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 603456 stock is "Buy." The 12-month stock price target is ¥19.20, which is an increase of 18.81% from the latest price.

Price Target

¥19.20

(18.81% upside)

Analyst Consensus: Buy

Stock Forecasts